High-Quality Medical Resources "Zero Distance" | Lanzhou Heavy Ion Hospital Expert Team Visits Dingxi: Academic Exchange Builds Bridges, Free Clinic Services Warm People's Hearts

To further promote the high-quality development of tumor prevention and treatment in Gansu Province, facilitate the downward transfer of high-level medical technology resources, and enhance grassroots tumor diagnosis and treatment capabilities, the "Mother River · Tumor Prevention and Treatment Public Welfare Project - Expert Grassroots Tour Activity," hosted by the Bethune Charitable Foundation and organized by Lanzhou Heavy Ion Hospital and Dingxi People's Hospital, was successfully held at Dingxi People's Hospital on September 19.

The event was attended by Wang Junjie, Director of the Radiotherapy Oncology Committee of the Chinese Medical Association, Chairman of the Radiotherapy Special Committee of the Bethune Charitable Foundation, Director of the Radiotherapy Department of Peking University Third Hospital, and President of Lanzhou Heavy Ion Hospital; Yin Le, Director of the Project Development Department of the Bethune Charitable Foundation; Professors Jiang Yuliang, Qu Ang, and Li Xuemin from Peking University Third Hospital; and medical colleagues from Lanzhou Heavy Ion Hospital, including Vice President Qi Ying, Professors Zhao Fengju, Pan Ming, and Zhang Yingdong.

The event included free clinics, academic exchanges, teaching ward rounds, and a signing and unveiling ceremony. National-level experts provided "face-to-face" diagnosis and treatment and "hands-on" teaching, allowing local residents to enjoy high-quality medical services at their doorstep. This effectively improved grassroots diagnosis and treatment levels and met the medical needs of patients.

Free Clinic Scene

Academic Exchange and Unveiling and Signing Ceremony

The academic exchange session involved experts and medical colleagues discussing cutting-edge knowledge and practical experience in the field of tumor treatment, providing a platform for academic exchange.

As the core highlight of the event, the unveiling ceremony of the "Lanzhou Heavy Ion Hospital Dingxi People's Hospital Expert Consultation Center" and the signing ceremony of the medical consortium marked a significant step. Tumor patients can now receive remote consultations and treatment guidance from top experts at Lanzhou Heavy Ion Hospital without traveling far, allowing them to benefit from this "cancer-fighting tool" at their doorstep.

Professor Wang Junjie: "The Path to High-Quality Development of Radiotherapy for Tumors in China"

Professor Zhao Fengju: "Cervical Cancer Screening, Quality Control, and Comprehensive Treatment"

Professor Zhang Yingdong: "Presentation of Typical Cases in Tumor Radiotherapy"

Professor Jiang Yuliang: "Clinical Application of Radioactive Particle Implantation"

Professor Qu Ang: "Comprehensive Application of Deep Hyperthermia and Radiotherapy for Locally Advanced Cervical Cancer"

Yin Le: "Introduction to the 'Mother River' Project"

Expert Consultation Center Accreditation Ceremony

Medical Consortium Signing Ceremony

The symposium featured speeches by Zhou Jieshang, President of Dingxi People's Hospital, and Professor Wang Junjie of Lanzhou Heavy Ion Hospital. The expert team provided valuable suggestions on key areas such as the development of new technologies and talent training, based on the hospital's development needs. They also engaged in in-depth discussions with hospital leaders on the future development plan of the radiotherapy department and provided professional and detailed answers to questions raised by the hospital.

In the future, Lanzhou Heavy Ion Center will continue to uphold the mission of "serving patients and contributing to society" by actively carrying out similar public welfare activities. This will provide high-quality medical services to more patients and contribute to the construction of a healthy Gansu.

Lanzhou Heavy Ion Center

Gansu Wuwei Cancer Hospital is a state-owned public Class III Grade A cancer specialty hospital. Lanzhou Heavy Ion Center is the second clinical application center for heavy ion therapy with independent intellectual property rights in China, operated by Gansu Wuwei Cancer Hospital. The second Chinese heavy ion tumor treatment system was put into clinical operation at Lanzhou Heavy Ion Center on November 15, 2024. To date, the center has completed photon and heavy ion treatment for over 300 patients, covering diseases such as lung cancer, pancreatic cancer, liver cancer, and brain glioma.

Lanzhou Heavy Ion Center has established an elite talent system, featuring expert workstations led by 50 industry-leading authorities, including Shen Wenjiang, Lifetime Honorary Professor of the Department of Radiotherapy Oncology at Peking University Health Science Center, and Professor Xu Bo, Standing Committee Member of the Radiotherapy Oncology Committee of the Chinese Medical Association. Professor Wang Junjie, Chairman of the Radiotherapy Oncology Committee of the Chinese Medical Association, serves as the president, providing strong technical support for heavy ion therapy.

Additionally, the hospital is equipped with a series of cutting-edge medical devices, including the Varian VitalBeam medical linear accelerator, Elekta Infinity four-dimensional image-guided linear accelerator, 3.0T simulation positioning MRI, GE 256-slice high-end CT, and Varian-192Ir imported afterloader. These hardware facilities lay a solid foundation for heavy ion therapy, ensuring efficiency and precision in the treatment process.

The hospital aims to build a comprehensive, full-life-cycle tumor treatment system. It has established departments such as Radiotherapy Oncology, Medical Oncology/Hematology, Surgical Oncology, Integrated Traditional Chinese and Western Medicine Oncology Rehabilitation, Critical Care Medicine, Digestive Endoscopy Center, Imaging Department, Laboratory Department, Ultrasound Department, Blood Bank, and Hematology Center Laboratory. The hospital provides comprehensive treatments including photon radiotherapy, chemotherapy, heavy ion therapy, internal medicine, and surgery, as well as services such as imaging, medical testing, ultrasound, and bone marrow cell morphology examination.